Met Life Investment Management, LLC Opti Nose, Inc. Transaction History

Met Life Investment Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.17 - $1.94 $45,812 - $75,962	39,156 New	39,156 $57,000
Q3 2020 Nov 13, 2020	SELL	$3.69 - $7.09 $59,202 - $113,751	-16,044 Closed	0 $0
Q2 2020 May 24, 2024	SELL	$3.58 - $7.44 $82,740 - $171,953	-23,112 Reduced 59.03%	16,044 $119 Million
Q2 2020 Jun 26, 2023	BUY	$3.58 - $7.44 $57,437 - $119,367	16,044 New	16,044 $119,000
Q2 2020 Mar 22, 2023	BUY	$3.58 - $7.44 $12,279 - $25,519	3,430 Added 27.19%	16,044 $119,000
Q2 2020 Aug 14, 2020	BUY	$3.58 - $7.44 $57,437 - $119,367	16,044 New	16,044 $119,000
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $73,665 - $150,358	-12,614 Closed	0 $0
Q3 2018 Jul 13, 2023	BUY	$12.43 - $29.76 $101,055 - $241,948	8,130 New	8,130 $101,000
Q3 2018 Mar 22, 2023	BUY	$12.43 - $29.76 $156,792 - $375,392	12,614 New	12,614 $156,000
Q3 2018 Nov 14, 2018	BUY	$12.43 - $29.76 $156,792 - $375,392	12,614 New	12,614 $157,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $42.5M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.